ProtoPulse · CNAS therapeutic protocols
Data updated 19 Oct 2026, 22:37 · printed from ProtoPulse
Data updated 19 Oct 2026, 22:37 · printed from ProtoPulse
LUSPATERCEPT
Active substance (INN) · ATC B03XA06 · 2 products authorised in Romania
1
Protocols it appears in
As a medicine of the protocol (in the title) or only mentioned in the text
| Code | Protocol | Status | Role | Sublist | GP |
|---|---|---|---|---|---|
| B03XA06 | LUSPATERCEPT | In force | medicine of the protocol | C2 P6.1 | NO |
| B03XA06-SMD | LUSPATERCEPT | In force | medicine of the protocol | C2-P3 | NO |
2
Authorised brand products (ANMDM)
The Romanian register of medicines for human use, updated daily
| Brand name | Form | Strength | Holder | ATC | Rx |
|---|---|---|---|---|---|
| REBLOZYL 25 mg | PULB. PT. SOL. INJ. | 50mg/ml | BRISTOL-MYERS SQUIBB PHARMA EEIG - IRLANDA | B03XA06 | PR |
| REBLOZYL 75 mg | PULB. PT. SOL. INJ. | 50mg/ml | BRISTOL-MYERS SQUIBB PHARMA EEIG - IRLANDA | B03XA06 | PR |